Yale Infectious Diseases
Yale Center for Infectious Disease
200 Orchard Street, Fl 1
New Haven, CT 06511
- Yale Infectious DiseasesYale Center for Infectious Disease200 Orchard Street, Fl 1New Haven, CT 06511
Mark Lustberg, PhD, MD
Infectious Diseases, HIV & AIDs Medicine
Patient type treated
Adult
Accepting new patients
No
Referral required
Not Applicable
Board Certified in
Infectious Diseases
Biography
Mark Lustberg, MD, PhD, is an infectious disease specialist who focuses on managing infectious diseases, including HIV and AIDS.
As an associate professor of internal medicine at Yale School of Medicine, Dr. Lustberg researches innovative strategies in the field of infectious diseases.
Dr. Lustberg earned his medical degree from the University of Maryland School of Medicine and a doctorate in epidemiology from the University of Maryland, Baltimore, Graduate School. He then furthered his training by completing a residency at York Hospital and a fellowship at Ohio State University Medical Center.
Titles
- Associate Professor of Internal Medicine (Infectious Diseases)
Education & Training
- FellowshipOhio State University Medical Center (2009)
- ResidencyYork Hospital (2007)
- MDUniversity of Maryland School of Medicine, Internal Medicine Infectious Diseases (2004)
- PhDUniversity of Maryland Baltimore Graduate School, Epidemiology (2002)
- BSUniversity of Maryland College Park, Biochemistry (1992)
Additional Information
Board Certifications
- American Board of Internal Medicine, Infectious Diseases (2019, recertified: 2022)
Publications
- Weigel C, Klimaszewski H, Tounkara F, Addissie S, Schlotter S, Pray B, Dugan J, Haverkos B, Villagomez L, Lustberg M, Porcu P, Voorhees T, Ambinder R, Kenney S, Fingeroth J, Delecluse H, Caligiuri M, Alinari L, Bumgardner G, Oakes C, Baiocchi R. Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease. Blood Neoplasia 2026, 3: 100200. PMID: 41808730, PMCID: PMC12969294, DOI: 10.1016/j.bneo.2026.100200.
- Noel C, Weigel C, Klimaszewski H, Host K, Wu Y, Schlotter S, Ahmed E, Brooks E, Blachly J, Lustberg M, Voorhees T, Oakes C, Baiocchi R. Assessment of EBV DNA methlyation to guide antiviral use in EBV-associated lymphoma. Blood 2025, 146: 1752-1752. DOI: 10.1182/blood-2025-1752.
- Lustberg M, Clark B. Anti-IL-5 Treatment Reduces Infection-Related Adverse Events: A Meta-Analysis of Phase 3 Clinical Trials. The Journal Of Allergy And Clinical Immunology In Practice 2025, 13: 1622-1631. PMID: 39947298, DOI: 10.1016/j.jaip.2025.01.037.
- Nichols C, Lustberg M, Sobhanie M, Niermann L, Gordon M, Kman N, Parsons J, Conroy M, Dick M, Allen J, Reed E, Lehman J, Malvestutto C. Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohort. Antiviral Therapy 2024, 29: 13596535241264694. PMID: 39066463, DOI: 10.1177/13596535241264694.
- McNally G, Aossey C, Wiczer T, Sinnott L, Lustberg M, Baiocchi R, Lustberg M. A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter? Leukemia & Lymphoma 2024, 65: 1110-1116. PMID: 38648546, DOI: 10.1080/10428194.2024.2340051.
- Patel Y, Doshi A, Levesque A, Lindor S, Moranville R, Okere S, Robinson D, Taylor L, Lustberg M, Malvestutto C. Weight Gain in People with HIV: The Role of Demographics, Antiretroviral Therapy, and Lifestyle Factors on Weight. AIDS Research And Human Retroviruses 2023, 39: 652-661. PMID: 37276145, DOI: 10.1089/aid.2023.0008.
- Klimaszewski H, Weigel C, Addissie S, Schlotter S, Fode T, Dugan J, Haverkos B, Villagomez L, Lustberg M, Porcu P, Voorhees T, Caligiuri M, Oakes C, Bumgardner G, Baiocchi R. Targeting EBV Encoded Viral Kinases with GCV, AZT, Rituximab and Dexamethasone (GARD) Results in Durable Responses in Patients with CNS Lymphoproliferative Disease. Blood 2023, 142: 4476. DOI: 10.1182/blood-2023-189618.
- Ahmed E, Lustberg M, Hale C, Sloan S, Mao C, Zhang X, Ozer H, Schlotter S, Smith P, Jeney F, Chan K, Harrington B, Weigel C, Brooks E, Klimaszewski H, Oakes C, Abebe T, Ibrahim M, Alinari L, Behbehani G, Shindiapina P, Caligiuri M, Baiocchi R. Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein–Barr Virus Lymphoproliferative Disorder. Cancers 2023, 15: 3046. PMID: 37297008, PMCID: PMC10252287, DOI: 10.3390/cancers15113046.
- Weigel C, Kautto E, Ahmed E, Wu Y, Gregory C, Cleary A, Schlotter S, Brooks E, Lustberg M, Baiocchi R, Blachly J, Oakes C. Methylome Analysis of Epstein-Barr Virus with Nanopore Sequencing Reveals Viral State Dynamics. Blood 2022, 140: 8772-8773. DOI: 10.1182/blood-2022-159739.
- Ahmed E, Lustberg M, Hale C, Sloan S, Mao C, Zhang X, Ozer H, Schlotter S, Jeney F, Chan W, Harrington B, Weigel C, Alinari L, Oakes C, Abebe T, Behbehani G, Shindiapina P, Caligiuri M, Baiocchi R. P1244: ROLE OF SELECT T HELPER CELL MONONUCLEAR CELL SUBSETS PROMOTING EPSTEIN‐BARR VIRUS‐DRIVEN LYMPHOPROLIFERATIVE DISEASE IN THE HU‐PBL‐SCID MODEL. HemaSphere 2022, 6: 1129-1130. PMCID: PMC9429323, DOI: 10.1097/01.hs9.0000847840.97069.60.
- Colburn N, Nichols C, Lustberg M, Day S, Haden M, Liscynesky C. Candidemia before and after the COVID-19 pandemic: An analysis of risk factors and outcomes in patients with candidemia. Antimicrobial Stewardship & Healthcare Epidemiology 2022, 2: s77-s78. PMCID: PMC9614847, DOI: 10.1017/ash.2022.204.
- Rozycki E, Weiner A, Malvestutto C, Kman N, Lustberg M, Dick M, Lehman K, Schieber A, Luca L, Jordan T, Reed E, Allen J, Parsons J, Nichols C, Conroy M. Evidence Based Scarce Resource Allocation During the COVID-19 Pandemic: A Case Study of Bamlanivimab Administration in the Emergency Department. Hospital Pharmacy 2022, 57: 639-645. PMID: 36081532, PMCID: PMC9445538, DOI: 10.1177/00185787211073466.
- Boghdadly Z, Zhao Q, Koutou J, Lustberg M, Ludwig M, Liscynesky C, Choe H. Evaluation of central line salvage for mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) management practices in patients with hematologic malignancies. Leukemia & Lymphoma 2022, 63: 1455-1463. PMID: 35001802, DOI: 10.1080/10428194.2021.2020778.
- Nichols C, Lustberg M, Sobhanie M, Lehman J, Reed E, Kman N, Conroy M, Dick M, Allen J, Parsons J, Malvestutto C. 553. Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Treatment with Monoclonal Antibody Therapy (MAT) in the Outpatient Setting. Open Forum Infectious Diseases 2021, 8: 379-379. PMCID: PMC8643966, DOI: 10.1093/ofid/ofab466.751.
- Nichols C, Lustberg M, Sobhanie M, Lehman J, Reed E, Kman N, Conroy M, Dick M, Allen J, Parsons J, Malvestutto C. 535. Comparison of Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Monoclonal Antibody Therapy (MAT) with Bamlamivimab or Casirivimab-Imdevimab. Open Forum Infectious Diseases 2021, 8: 369-369. PMCID: PMC8690747, DOI: 10.1093/ofid/ofab466.734.
- Al-Saadi M, Malvestutto C, Sobhanie M, Hebert C, Colburn N, Lustberg M. 318. Description of Patients Readmitted within 30 Days from COVID-19 Hospitalization. Open Forum Infectious Diseases 2021, 8: 264-265. PMCID: PMC8644209, DOI: 10.1093/ofid/ofab466.520.
- Patel Y, Doshi A, Levesque A, Lindor S, Moranville R, Okere S, Robinson D, Taylor L, Lustberg M, Malvestutto C. 835. Improvement in Diet Attenuates Antiretroviral Therapy (ART) Associated Weight Gain in Persons with Human Immunodeficiency Virus (PWH). Open Forum Infectious Diseases 2021, 8: 509-510. PMCID: PMC8644091, DOI: 10.1093/ofid/ofab466.1031.
- Patel Y, Doshi A, Levesque A, Lindor S, Moranville R, Okere S, Robinson D, Taylor L, Lustberg M, Malvestutto C. 822. Tenofovir Alafenamide (TAF) is an Independent Risk Factor for Hyperlipidemia in Persons with Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy (ART). Open Forum Infectious Diseases 2021, 8: 504-504. DOI: 10.1093/ofid/ofab466.1018.
- Koenig K, Curley T, Mani S, Keiter A, Zhao Q, Behbehani G, Bhatnagar B, Blachly J, Haque T, Larkin K, Long M, Mims A, Vasu S, Wall S, Byrd J, Lustberg M, Walker A, Grieselhuber N. Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients. Hematological Oncology 2021, 40: 116-119. PMID: 34713477, DOI: 10.1002/hon.2941.
- Lipps A, Bazan J, Lustberg M, Sobhanie M, Pollak B, Nandam K, Koletar S, Lindsey S, Dick M, Malvestutto C. A Collaborative Intervention Between Emergency Medicine and Infectious Diseases to Increase Syphilis and HIV Screening in the Emergency Department. Sexually Transmitted Diseases 2021, 49: 50-54. PMID: 34108412, PMCID: PMC8663525, DOI: 10.1097/olq.0000000000001496.
- El Boghdadly Z, Sarwar S, Lustberg M. Infectious Challenges with Novel Antibody–Based Therapies. Current Infectious Disease Reports 2021, 23: 10. DOI: 10.1007/s11908-021-00753-2.
- Singha A, Burcham P, Logan A, Boghdadly Z, Howsare M, Nunley D, Lustberg M, Keller B. Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant Patients with Valganciclovir-Induced Leukopenia. Transplantology 2021, 2: 129-139. DOI: 10.3390/transplantology2020013.
- Nichols C, Sobhanie M, Colburn N, Lustberg M, Boghdadly Z, Liscynesky C, Hebert C, Day S. 367. Clinical Characteristics and Outcomes in Patients with Pneumonia secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Open Forum Infectious Diseases 2020, 7: s253-s253. PMCID: PMC7777504, DOI: 10.1093/ofid/ofaa439.562.
- Patel Y, Okere S, Lustberg M, Malvestutto C. 951. Weight Gain Associated With Antiretroviral Therapy. Open Forum Infectious Diseases 2020, 7: s508-s508. PMCID: PMC7776257, DOI: 10.1093/ofid/ofaa439.1137.
- Ozga M, Huang Y, Blachly J, Grieselhuber N, Wall S, Larkin K, Haque T, Walker A, Bhatnagar B, Behbehani G, Vasu S, Maakaron J, Lustberg M, Mims A. The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating Agent. Clinical Lymphoma Myeloma & Leukemia 2020, 21: e76-e83. PMID: 32921593, DOI: 10.1016/j.clml.2020.08.013.
- Hebert C, Gao Y, Rahman P, Dewart C, Lustberg M, Pancholi P, Stevenson K, Shah N, Hade E. Prediction of Antibiotic Susceptibility for Urinary Tract Infection in a Hospital Setting. Antimicrobial Agents And Chemotherapy 2020, 64: 10.1128/aac.02236-19. PMID: 32312778, PMCID: PMC7318043, DOI: 10.1128/aac.02236-19.
- Mezzanotte J, Gibbons-Fideler I, Shilo K, Lustberg M, Devarakonda S. Nodular pulmonary deposition disease in a patient with the acquired immunodeficiency syndrome: a case report. Journal Of Medical Case Reports 2020, 14: 64. PMID: 32498712, PMCID: PMC7273682, DOI: 10.1186/s13256-020-02394-w.
- Curley T, Koenig K, Mani S, Lustberg M, Behbehani G, Bhatnagar B, Blachly J, Haque T, Larkin K, Long M, Mims A, Vasu S, Wall S, Byrd J, Walker A, Grieselhuber N. Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients. Journal Of Clinical Oncology 2020, 38: e19510-e19510. DOI: 10.1200/jco.2020.38.15_suppl.e19510.
- Dewart C, Hade E, Gao Y, Rahman P, Lustberg M, Pancholi P, Stevenson K, Hebert C. 2208. Development and Evaluation of Predictive Models for Estimating Infection Susceptibility to Empiric Treatment Regimens Among Patients with Pneumonia in Intensive Care Units. Open Forum Infectious Diseases 2019, 6: s753-s753. PMCID: PMC6810292, DOI: 10.1093/ofid/ofz360.1886.
- Ingnam S, Flaherty J, Lustberg M, Mangino J, Day S. 1242. Evaluation of Risk Factors for Development of Total Hip Arthroplasty (THA) Surgical Site Infections (SSI). Open Forum Infectious Diseases 2019, 6: s447-s447. PMCID: PMC6809298, DOI: 10.1093/ofid/ofz360.1105.
- Hebert C, Gao Y, Rahman P, Dewart C, Shah N, Lustberg M, Stevenson K, Pancholi P, Hade E. 1433. Predictive Models for Antibiotic Coverage of Gram-Negative Urinary Tract Infections. Open Forum Infectious Diseases 2019, 6: s523-s523. PMCID: PMC6809692, DOI: 10.1093/ofid/ofz360.1297.
- Boghdadly Z, Liscynesky C, Lustberg M, Neal A, Dickman J, Choe H. Management of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBIs) in Stem Cell Transplant Recipients: A National Survey of Cancer Centers Practices. Transplantation And Cellular Therapy 2019, 25: s356. DOI: 10.1016/j.bbmt.2018.12.577.
- Hebert C, Hade E, Rahman P, Lustberg M, Dewart C, Pancholi P, Stevenson K. 1515. Patient-Based Stratification of Weighted-Incidence Syndromic Antibiogram (WISCA) for Empiric Antibiotic Prescribing. Open Forum Infectious Diseases 2018, 5: s469-s469. PMCID: PMC6253908, DOI: 10.1093/ofid/ofy210.1344.
- Dugan J, Haverkos B, Villagomez L, Martin L, Lustberg M, Patton J, Martin M, Huang Y, Nuovo G, Yan F, Cavaliere R, Fingeroth J, Kenney S, Ambinder R, Lozanski G, Porcu P, Caligiuri M, Baiocchi R. Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone. Clinical Cancer Research 2018, 24: 3273-3281. PMID: 29632007, PMCID: PMC6050103, DOI: 10.1158/1078-0432.ccr-17-2685.
- Patterson E, Dewart C, Stevenson K, Mbodj A, Lustberg M, Hade E, Hebert C. A Mixed Methods Approach to Tailoring Evidence-Based Guidance for Antibiotic Stewardship to One Medical System. Proceedings Of The International Symposium On Human Factors And Ergonomics In Health Care 2018, 7: 224-231. PMID: 30046637, PMCID: PMC6056269, DOI: 10.1177/2327857918071053.
- Hebert C, Hade E, Rahman P, Lustberg M, Stevenson K, Pancholi P. Modeling Likelihood of Coverage for Narrow Spectrum Antibiotics in Patients Hospitalized with Urinary Tract Infections. Open Forum Infectious Diseases 2017, 4: s281-s282. PMCID: PMC5632149, DOI: 10.1093/ofid/ofx163.632.
- Dean S, Kaffenberger B, Lustberg M. Kaposi sarcoma: An unconventional cause of lower extremity lymphedema. Vascular Medicine 2017, 22: 544-544. PMID: 28875759, DOI: 10.1177/1358863x17729031.
- Pennell B, Hussain C, Theodoropoulos N, Mangino J, Tubbs C, Lustberg M, Zhang C, Reed E. Safety and Efficacy of Fecal Microbiota Transplants for the Treatment of Clostridium difficile at a Tertiary Care Academic Medical Center. Open Forum Infectious Diseases 2016, 3: 1208. DOI: 10.1093/ofid/ofw172.911.
- Anwar M, Johnston J, Reed E, Lustberg M, Stevenson K, Andritsos L, Devine S, Martin S. Antimicrobial Use for Febrile Neutropenia in Patients with Hematologic Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplant and Clinical Outcome. Transplantation And Cellular Therapy 2016, 22: s158. DOI: 10.1016/j.bbmt.2015.11.514.
- Mates J, de Silva S, Lustberg M, Van Deusen K, Baiocchi R, Wu L, Kwiek J. A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4+ T-cells. 2015, 7: 1-5. PMID: 26855567, PMCID: PMC4739806, DOI: 10.4137/rrt.s31632.
- Hartlage A, Liu T, Patton J, Garman S, Zhang X, Kurt H, Lozanski G, Lustberg M, Caligiuri M, Baiocchi R. The Epstein–Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development. Cancer Immunology Research 2015, 3: 787-794. PMID: 25735952, PMCID: PMC4491000, DOI: 10.1158/2326-6066.cir-14-0242.
- Lustberg M, Pelletier R, Porcu P, Martin S, Quinion C, Geyer S, Caligiuri M, Baiocchi R. Human Leukocyte Antigen Type and Posttransplant Lymphoproliferative Disorder. Transplantation 2015, 99: 1220-1225. PMID: 25427163, DOI: 10.1097/tp.0000000000000487.
- Hartlage A, Liu T, Patton J, Garman S, Zhang X, Kurt H, Lozanski G, Lustberg M, Caligiuri M, Baiocchi R. The Epstein-Barr Virus Lytic Protein BZLF1 As a Candidate Target Antigen for Vaccine Development. Blood 2014, 124: 4144. DOI: 10.1182/blood.v124.21.4144.4144.
- Dugan J, Haverkos B, Martin L, Martin M, Lustberg M, Patton J, Nuovo G, Yan F, Cavaliere R, Kenney S, Fingeroth J, Lozanski G, Ramos J, Porcu P, Caligiuri M, Baiocchi R. Epstein-Barr Virus Kinase-Targeted Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder. Blood 2014, 124: 1750. DOI: 10.1182/blood.v124.21.1750.1750.
- Patton J, Lustberg M, Lozanski G, Garman S, Towns W, Drohan C, Lehman A, Zhang X, Bolon B, Pan L, Kinghorn A, Grever M, Lucas D, Baiocchi R. The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease. Oncotarget 2014, 6: 2693-2708. PMID: 25393910, PMCID: PMC4413611, DOI: 10.18632/oncotarget.2098.
- Haverkos B, Hemminger J, Geyer S, Bingman A, Van Deusen K, Lustberg M, Wong H, Gru A, Ambinder R, Baiocchi R, Porcu P. Prognostic implications, predictive value, and latency analysis of Epstein-Barr virus (EBV) DNA in advanced stage cutaneous T-cell lymphoma (AS-CTCL). Journal Of Clinical Oncology 2014, 32: e19518-e19518. DOI: 10.1200/jco.2014.32.15_suppl.e19518.
- Yan F, Alinari L, Lustberg M, Martin L, Cordero-Nieves H, Banasavadi-Siddegowda Y, Virk S, Barnholtz-Sloan J, Bell E, Wojton J, Jacob N, Chakravarti A, Nowicki M, Wu X, Lapalombella R, Datta J, Yu B, Gordon K, Haseley A, Patton J, Smith P, Ryu J, Zhang X, Mo X, Marcucci G, Nuovo G, Kwon C, Byrd J, Chiocca E, Li C, Sif S, Jacob S, Lawler S, Kaur B, Baiocchi R. Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma. Cancer Research 2014, 74: 1752-1765. PMID: 24453002, PMCID: PMC3959215, DOI: 10.1158/0008-5472.can-13-0884.
- Abandeh F, Lustberg M, Devine S, Elder P, Andritsos L, Martin S. Outcomes of hematopoietic SCT recipients with rhinovirus infection: a matched, case–control study. Bone Marrow Transplantation 2013, 48: 1554-1557. PMID: 23872740, PMCID: PMC4606879, DOI: 10.1038/bmt.2013.100.
- Lustberg M, Bauer K. How Much Is a Life Worth? Food for Thought. Clinical Infectious Diseases 2013, 57: 627-628. PMID: 23658432, PMCID: PMC3719888, DOI: 10.1093/cid/cit311.
- Sopirala M, Smyer J, Fawley L, Mangino J, Lustberg M, Lu J, Chucta S, Crouser E. Sustained reduction of central line–associated bloodstream infections in an intensive care unit using a top-down and bottom-up approach. American Journal Of Infection Control 2013, 41: 183-184. PMID: 23369315, DOI: 10.1016/j.ajic.2012.07.013.
- Exline M, Ali N, Zikri N, Mangino J, Torrence K, Vermillion B, St Clair J, Lustberg M, Pancholi P, Sopirala M. Beyond the bundle - journey of a tertiary care medical intensive care unit to zerocentral line-associated bloodstream infections. Critical Care 2013, 17: r41. PMID: 23497591, PMCID: PMC3733431, DOI: 10.1186/cc12551.
- Hofmeister C, Bowers M, Bingman A, Lozanski G, Baiocchi R, Falk W, Benson D, Efebera Y, Humphries K, Sell M, Greenfield C, Lustberg M, Vaughn J, Earl C, Geyer S, Devine S. Immune Reconstitution and Quality of Life Analyses After Autologous Transplant for Multiple Myeloma. Blood 2012, 120: 4460. DOI: 10.1182/blood.v120.21.4460.4460.
- Alinari L, Yan F, Smith P, Patton J, Quinion C, Yu B, Earl C, Lustberg M, Villagomez L, Hertlein E, Byrd J, Ayers L, Motiwala T, Majumder S, Li C, Sif S, Jacob S, Baiocchi R. Protein Arginine Methyltransferase 5 (PRMT5) Over-Expression Is Essential for Epstein-Barr Virus-Driven B-Cell Transformation. Blood 2012, 120: 2378. DOI: 10.1182/blood.v120.21.2378.2378.
- Hofmeister C, Bowers M, Baiocchi R, Lozanski G, Humphries K, Blum K, Porcu P, Penza S, Greenfield C, Sell M, Earl C, Zitesman J, Quinion C, Lustberg M, Andritsos L, Devine S. Post Autologous Transplant Vorinostat (SAHA) in High Risk Lymphoma: Phase 1 Study of Vorinostat Maintenance. Blood 2012, 120: 2004. DOI: 10.1182/blood.v120.21.2004.2004.
- Stevenson K, Balada-Llasat J, Bauer K, Deutscher M, Goff D, Lustberg M, Pancholi P, Reed E, Smeenk D, Taylor J, West J. The Economics of Antimicrobial Stewardship: The Current State of the Art and Applying the Business Case Model. Infection Control And Hospital Epidemiology 2012, 33: 389-397. PMID: 22418635, DOI: 10.1086/664910.
- Martin L, Lustberg M, Yan F, Patton J, Porcu P, Nuovo G, Cavaliere R, Baiocchi R. Successful Treatment of Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder (PCNS-PTLD) with Zidovudine (AZT), Ganciclovir (GCV), Rituximab and Dexamethasone: A Single-Institution Case Series. Blood 2011, 118: 3067. DOI: 10.1182/blood.v118.21.3067.3067.
- Lustberg M, Pelletier R, Porcu P, Martin S, Baiocchi R. Risk Factors for Post-Transplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients. Blood 2011, 118: 4465. DOI: 10.1182/blood.v118.21.4465.4465.
- Patton J, Lustberg M, Garman S, Kinghorn A, Pan L, Lucas D, Grever M, Baiocchi R. Silvestrol Modulates Direct Anti-Tumor Activity Against Epstein-Barr Virus (EBV)-Associated Lymphomas While Sparing Innate and Antigen Specific Adaptive Immunity. Blood 2011, 118: 104. DOI: 10.1182/blood.v118.21.104.104.
- Christian B, Alinari L, Jones J, Benson D, Flynn J, Porcu P, Lustberg M, Phelps M, Poi M, Chung D, Quinion C, Byrd J, Wegener W, Goldenberg D, Baiocchi R, Blum K. Results of A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma,. Blood 2011, 118: 3707. DOI: 10.1182/blood.v118.21.3707.3707.
- Alinari L, Yu B, Christian B, Yan F, Shin J, Lapalombella R, Hertlein E, Lustberg M, Quinion C, Zhang X, Lozanski G, Muthusamy N, Prætorius-Ibba M, O'Connor O, Goldenberg D, Byrd J, Blum K, Baiocchi R. Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma. Blood 2011, 117: 4530-4541. PMID: 21228331, PMCID: PMC3099572, DOI: 10.1182/blood-2010-08-303354.
- Baiocchi R, Alinari L, Lustberg M, Lin T, Porcu P, Li X, Johnston J, Byrd J, Blum K. Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma. Cancer 2010, 117: 2442-2451. PMID: 24048792, PMCID: PMC3116936, DOI: 10.1002/cncr.25792.
- Christian B, Alinari L, Earl C, Wilding E, Quinion C, Lustberg M, Benson D, Jones J, Byrd J, Wegener W, Goldenberg D, Baiocchi R, Blum K. A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma. Blood 2010, 116: 2788. DOI: 10.1182/blood.v116.21.2788.2788.
- Ramaswamy B, Phelps M, Baiocchi R, Bekaii-Saab T, Ni W, Lai J, Wolfson A, Lustberg M, Wei L, Wilkins D, Campbell A, Arbogast D, Doyle A, Byrd J, Grever M, Shah M. A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors. Investigational New Drugs 2010, 30: 629-638. PMID: 20938713, PMCID: PMC3486515, DOI: 10.1007/s10637-010-9563-7.
- Lustberg M, Bekaii-Saab T, Young D, Otterson G, Burak W, Abbas A, McCracken-Bussa B, Lustberg M, Villalona-Calero M. Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients with Unresectable Esophageal and Gastroesophageal Adenocarcinoma. Journal Of Thoracic Oncology 2010, 5: 713-718. PMID: 20354452, PMCID: PMC3641556, DOI: 10.1097/jto.0b013e3181d7776d.
- Lustberg M, Schlesinger L, Mangino J. Concerns about “Complicated Skin and Skin-Structure Infections and Catheter-Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study”. Clinical Infectious Diseases 2009, 49: 313-313. PMID: 19538067, PMCID: PMC4117394, DOI: 10.1086/600056.
- Lustberg M. Shock as a Covariate in a Study of Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Clinical Infectious Diseases 2008, 46: 1483-1483. PMID: 18419465, DOI: 10.1086/587178.
Departments and Programs
Locations
Yale Infectious Diseases
Yale Center for Infectious Disease
200 Orchard Street, Fl 1
New Haven, CT 06511
- Yale Infectious DiseasesYale Center for Infectious Disease200 Orchard Street, Fl 1New Haven, CT 06511
Biography
Mark Lustberg, MD, PhD, is an infectious disease specialist who focuses on managing infectious diseases, including HIV and AIDS.
As an associate professor of internal medicine at Yale School of Medicine, Dr. Lustberg researches innovative strategies in the field of infectious diseases.
Dr. Lustberg earned his medical degree from the University of Maryland School of Medicine and a doctorate in epidemiology from the University of Maryland, Baltimore, Graduate School. He then furthered his training by completing a residency at York Hospital and a fellowship at Ohio State University Medical Center.
Titles
- Associate Professor of Internal Medicine (Infectious Diseases)
Education & Training
- FellowshipOhio State University Medical Center (2009)
- ResidencyYork Hospital (2007)
- MDUniversity of Maryland School of Medicine, Internal Medicine Infectious Diseases (2004)
- PhDUniversity of Maryland Baltimore Graduate School, Epidemiology (2002)
- BSUniversity of Maryland College Park, Biochemistry (1992)
Additional Information
Board Certifications
- American Board of Internal Medicine, Infectious Diseases (2019, recertified: 2022)
Publications
- Weigel C, Klimaszewski H, Tounkara F, Addissie S, Schlotter S, Pray B, Dugan J, Haverkos B, Villagomez L, Lustberg M, Porcu P, Voorhees T, Ambinder R, Kenney S, Fingeroth J, Delecluse H, Caligiuri M, Alinari L, Bumgardner G, Oakes C, Baiocchi R. Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease. Blood Neoplasia 2026, 3: 100200. PMID: 41808730, PMCID: PMC12969294, DOI: 10.1016/j.bneo.2026.100200.
- Noel C, Weigel C, Klimaszewski H, Host K, Wu Y, Schlotter S, Ahmed E, Brooks E, Blachly J, Lustberg M, Voorhees T, Oakes C, Baiocchi R. Assessment of EBV DNA methlyation to guide antiviral use in EBV-associated lymphoma. Blood 2025, 146: 1752-1752. DOI: 10.1182/blood-2025-1752.
- Lustberg M, Clark B. Anti-IL-5 Treatment Reduces Infection-Related Adverse Events: A Meta-Analysis of Phase 3 Clinical Trials. The Journal Of Allergy And Clinical Immunology In Practice 2025, 13: 1622-1631. PMID: 39947298, DOI: 10.1016/j.jaip.2025.01.037.
- Nichols C, Lustberg M, Sobhanie M, Niermann L, Gordon M, Kman N, Parsons J, Conroy M, Dick M, Allen J, Reed E, Lehman J, Malvestutto C. Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohort. Antiviral Therapy 2024, 29: 13596535241264694. PMID: 39066463, DOI: 10.1177/13596535241264694.
- McNally G, Aossey C, Wiczer T, Sinnott L, Lustberg M, Baiocchi R, Lustberg M. A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter? Leukemia & Lymphoma 2024, 65: 1110-1116. PMID: 38648546, DOI: 10.1080/10428194.2024.2340051.
- Patel Y, Doshi A, Levesque A, Lindor S, Moranville R, Okere S, Robinson D, Taylor L, Lustberg M, Malvestutto C. Weight Gain in People with HIV: The Role of Demographics, Antiretroviral Therapy, and Lifestyle Factors on Weight. AIDS Research And Human Retroviruses 2023, 39: 652-661. PMID: 37276145, DOI: 10.1089/aid.2023.0008.
- Klimaszewski H, Weigel C, Addissie S, Schlotter S, Fode T, Dugan J, Haverkos B, Villagomez L, Lustberg M, Porcu P, Voorhees T, Caligiuri M, Oakes C, Bumgardner G, Baiocchi R. Targeting EBV Encoded Viral Kinases with GCV, AZT, Rituximab and Dexamethasone (GARD) Results in Durable Responses in Patients with CNS Lymphoproliferative Disease. Blood 2023, 142: 4476. DOI: 10.1182/blood-2023-189618.
- Ahmed E, Lustberg M, Hale C, Sloan S, Mao C, Zhang X, Ozer H, Schlotter S, Smith P, Jeney F, Chan K, Harrington B, Weigel C, Brooks E, Klimaszewski H, Oakes C, Abebe T, Ibrahim M, Alinari L, Behbehani G, Shindiapina P, Caligiuri M, Baiocchi R. Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein–Barr Virus Lymphoproliferative Disorder. Cancers 2023, 15: 3046. PMID: 37297008, PMCID: PMC10252287, DOI: 10.3390/cancers15113046.
- Weigel C, Kautto E, Ahmed E, Wu Y, Gregory C, Cleary A, Schlotter S, Brooks E, Lustberg M, Baiocchi R, Blachly J, Oakes C. Methylome Analysis of Epstein-Barr Virus with Nanopore Sequencing Reveals Viral State Dynamics. Blood 2022, 140: 8772-8773. DOI: 10.1182/blood-2022-159739.
- Ahmed E, Lustberg M, Hale C, Sloan S, Mao C, Zhang X, Ozer H, Schlotter S, Jeney F, Chan W, Harrington B, Weigel C, Alinari L, Oakes C, Abebe T, Behbehani G, Shindiapina P, Caligiuri M, Baiocchi R. P1244: ROLE OF SELECT T HELPER CELL MONONUCLEAR CELL SUBSETS PROMOTING EPSTEIN‐BARR VIRUS‐DRIVEN LYMPHOPROLIFERATIVE DISEASE IN THE HU‐PBL‐SCID MODEL. HemaSphere 2022, 6: 1129-1130. PMCID: PMC9429323, DOI: 10.1097/01.hs9.0000847840.97069.60.
- Colburn N, Nichols C, Lustberg M, Day S, Haden M, Liscynesky C. Candidemia before and after the COVID-19 pandemic: An analysis of risk factors and outcomes in patients with candidemia. Antimicrobial Stewardship & Healthcare Epidemiology 2022, 2: s77-s78. PMCID: PMC9614847, DOI: 10.1017/ash.2022.204.
- Rozycki E, Weiner A, Malvestutto C, Kman N, Lustberg M, Dick M, Lehman K, Schieber A, Luca L, Jordan T, Reed E, Allen J, Parsons J, Nichols C, Conroy M. Evidence Based Scarce Resource Allocation During the COVID-19 Pandemic: A Case Study of Bamlanivimab Administration in the Emergency Department. Hospital Pharmacy 2022, 57: 639-645. PMID: 36081532, PMCID: PMC9445538, DOI: 10.1177/00185787211073466.
- Boghdadly Z, Zhao Q, Koutou J, Lustberg M, Ludwig M, Liscynesky C, Choe H. Evaluation of central line salvage for mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) management practices in patients with hematologic malignancies. Leukemia & Lymphoma 2022, 63: 1455-1463. PMID: 35001802, DOI: 10.1080/10428194.2021.2020778.
- Nichols C, Lustberg M, Sobhanie M, Lehman J, Reed E, Kman N, Conroy M, Dick M, Allen J, Parsons J, Malvestutto C. 553. Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Treatment with Monoclonal Antibody Therapy (MAT) in the Outpatient Setting. Open Forum Infectious Diseases 2021, 8: 379-379. PMCID: PMC8643966, DOI: 10.1093/ofid/ofab466.751.
- Nichols C, Lustberg M, Sobhanie M, Lehman J, Reed E, Kman N, Conroy M, Dick M, Allen J, Parsons J, Malvestutto C. 535. Comparison of Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Monoclonal Antibody Therapy (MAT) with Bamlamivimab or Casirivimab-Imdevimab. Open Forum Infectious Diseases 2021, 8: 369-369. PMCID: PMC8690747, DOI: 10.1093/ofid/ofab466.734.
- Al-Saadi M, Malvestutto C, Sobhanie M, Hebert C, Colburn N, Lustberg M. 318. Description of Patients Readmitted within 30 Days from COVID-19 Hospitalization. Open Forum Infectious Diseases 2021, 8: 264-265. PMCID: PMC8644209, DOI: 10.1093/ofid/ofab466.520.
- Patel Y, Doshi A, Levesque A, Lindor S, Moranville R, Okere S, Robinson D, Taylor L, Lustberg M, Malvestutto C. 835. Improvement in Diet Attenuates Antiretroviral Therapy (ART) Associated Weight Gain in Persons with Human Immunodeficiency Virus (PWH). Open Forum Infectious Diseases 2021, 8: 509-510. PMCID: PMC8644091, DOI: 10.1093/ofid/ofab466.1031.
- Patel Y, Doshi A, Levesque A, Lindor S, Moranville R, Okere S, Robinson D, Taylor L, Lustberg M, Malvestutto C. 822. Tenofovir Alafenamide (TAF) is an Independent Risk Factor for Hyperlipidemia in Persons with Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy (ART). Open Forum Infectious Diseases 2021, 8: 504-504. DOI: 10.1093/ofid/ofab466.1018.
- Koenig K, Curley T, Mani S, Keiter A, Zhao Q, Behbehani G, Bhatnagar B, Blachly J, Haque T, Larkin K, Long M, Mims A, Vasu S, Wall S, Byrd J, Lustberg M, Walker A, Grieselhuber N. Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients. Hematological Oncology 2021, 40: 116-119. PMID: 34713477, DOI: 10.1002/hon.2941.
- Lipps A, Bazan J, Lustberg M, Sobhanie M, Pollak B, Nandam K, Koletar S, Lindsey S, Dick M, Malvestutto C. A Collaborative Intervention Between Emergency Medicine and Infectious Diseases to Increase Syphilis and HIV Screening in the Emergency Department. Sexually Transmitted Diseases 2021, 49: 50-54. PMID: 34108412, PMCID: PMC8663525, DOI: 10.1097/olq.0000000000001496.
- El Boghdadly Z, Sarwar S, Lustberg M. Infectious Challenges with Novel Antibody–Based Therapies. Current Infectious Disease Reports 2021, 23: 10. DOI: 10.1007/s11908-021-00753-2.
- Singha A, Burcham P, Logan A, Boghdadly Z, Howsare M, Nunley D, Lustberg M, Keller B. Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant Patients with Valganciclovir-Induced Leukopenia. Transplantology 2021, 2: 129-139. DOI: 10.3390/transplantology2020013.
- Nichols C, Sobhanie M, Colburn N, Lustberg M, Boghdadly Z, Liscynesky C, Hebert C, Day S. 367. Clinical Characteristics and Outcomes in Patients with Pneumonia secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Open Forum Infectious Diseases 2020, 7: s253-s253. PMCID: PMC7777504, DOI: 10.1093/ofid/ofaa439.562.
- Patel Y, Okere S, Lustberg M, Malvestutto C. 951. Weight Gain Associated With Antiretroviral Therapy. Open Forum Infectious Diseases 2020, 7: s508-s508. PMCID: PMC7776257, DOI: 10.1093/ofid/ofaa439.1137.
- Ozga M, Huang Y, Blachly J, Grieselhuber N, Wall S, Larkin K, Haque T, Walker A, Bhatnagar B, Behbehani G, Vasu S, Maakaron J, Lustberg M, Mims A. The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating Agent. Clinical Lymphoma Myeloma & Leukemia 2020, 21: e76-e83. PMID: 32921593, DOI: 10.1016/j.clml.2020.08.013.
- Hebert C, Gao Y, Rahman P, Dewart C, Lustberg M, Pancholi P, Stevenson K, Shah N, Hade E. Prediction of Antibiotic Susceptibility for Urinary Tract Infection in a Hospital Setting. Antimicrobial Agents And Chemotherapy 2020, 64: 10.1128/aac.02236-19. PMID: 32312778, PMCID: PMC7318043, DOI: 10.1128/aac.02236-19.
- Mezzanotte J, Gibbons-Fideler I, Shilo K, Lustberg M, Devarakonda S. Nodular pulmonary deposition disease in a patient with the acquired immunodeficiency syndrome: a case report. Journal Of Medical Case Reports 2020, 14: 64. PMID: 32498712, PMCID: PMC7273682, DOI: 10.1186/s13256-020-02394-w.
- Curley T, Koenig K, Mani S, Lustberg M, Behbehani G, Bhatnagar B, Blachly J, Haque T, Larkin K, Long M, Mims A, Vasu S, Wall S, Byrd J, Walker A, Grieselhuber N. Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients. Journal Of Clinical Oncology 2020, 38: e19510-e19510. DOI: 10.1200/jco.2020.38.15_suppl.e19510.
- Dewart C, Hade E, Gao Y, Rahman P, Lustberg M, Pancholi P, Stevenson K, Hebert C. 2208. Development and Evaluation of Predictive Models for Estimating Infection Susceptibility to Empiric Treatment Regimens Among Patients with Pneumonia in Intensive Care Units. Open Forum Infectious Diseases 2019, 6: s753-s753. PMCID: PMC6810292, DOI: 10.1093/ofid/ofz360.1886.
- Ingnam S, Flaherty J, Lustberg M, Mangino J, Day S. 1242. Evaluation of Risk Factors for Development of Total Hip Arthroplasty (THA) Surgical Site Infections (SSI). Open Forum Infectious Diseases 2019, 6: s447-s447. PMCID: PMC6809298, DOI: 10.1093/ofid/ofz360.1105.
- Hebert C, Gao Y, Rahman P, Dewart C, Shah N, Lustberg M, Stevenson K, Pancholi P, Hade E. 1433. Predictive Models for Antibiotic Coverage of Gram-Negative Urinary Tract Infections. Open Forum Infectious Diseases 2019, 6: s523-s523. PMCID: PMC6809692, DOI: 10.1093/ofid/ofz360.1297.
- Boghdadly Z, Liscynesky C, Lustberg M, Neal A, Dickman J, Choe H. Management of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBIs) in Stem Cell Transplant Recipients: A National Survey of Cancer Centers Practices. Transplantation And Cellular Therapy 2019, 25: s356. DOI: 10.1016/j.bbmt.2018.12.577.
- Hebert C, Hade E, Rahman P, Lustberg M, Dewart C, Pancholi P, Stevenson K. 1515. Patient-Based Stratification of Weighted-Incidence Syndromic Antibiogram (WISCA) for Empiric Antibiotic Prescribing. Open Forum Infectious Diseases 2018, 5: s469-s469. PMCID: PMC6253908, DOI: 10.1093/ofid/ofy210.1344.
- Dugan J, Haverkos B, Villagomez L, Martin L, Lustberg M, Patton J, Martin M, Huang Y, Nuovo G, Yan F, Cavaliere R, Fingeroth J, Kenney S, Ambinder R, Lozanski G, Porcu P, Caligiuri M, Baiocchi R. Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone. Clinical Cancer Research 2018, 24: 3273-3281. PMID: 29632007, PMCID: PMC6050103, DOI: 10.1158/1078-0432.ccr-17-2685.
- Patterson E, Dewart C, Stevenson K, Mbodj A, Lustberg M, Hade E, Hebert C. A Mixed Methods Approach to Tailoring Evidence-Based Guidance for Antibiotic Stewardship to One Medical System. Proceedings Of The International Symposium On Human Factors And Ergonomics In Health Care 2018, 7: 224-231. PMID: 30046637, PMCID: PMC6056269, DOI: 10.1177/2327857918071053.
- Hebert C, Hade E, Rahman P, Lustberg M, Stevenson K, Pancholi P. Modeling Likelihood of Coverage for Narrow Spectrum Antibiotics in Patients Hospitalized with Urinary Tract Infections. Open Forum Infectious Diseases 2017, 4: s281-s282. PMCID: PMC5632149, DOI: 10.1093/ofid/ofx163.632.
- Dean S, Kaffenberger B, Lustberg M. Kaposi sarcoma: An unconventional cause of lower extremity lymphedema. Vascular Medicine 2017, 22: 544-544. PMID: 28875759, DOI: 10.1177/1358863x17729031.
- Pennell B, Hussain C, Theodoropoulos N, Mangino J, Tubbs C, Lustberg M, Zhang C, Reed E. Safety and Efficacy of Fecal Microbiota Transplants for the Treatment of Clostridium difficile at a Tertiary Care Academic Medical Center. Open Forum Infectious Diseases 2016, 3: 1208. DOI: 10.1093/ofid/ofw172.911.
- Anwar M, Johnston J, Reed E, Lustberg M, Stevenson K, Andritsos L, Devine S, Martin S. Antimicrobial Use for Febrile Neutropenia in Patients with Hematologic Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplant and Clinical Outcome. Transplantation And Cellular Therapy 2016, 22: s158. DOI: 10.1016/j.bbmt.2015.11.514.
- Mates J, de Silva S, Lustberg M, Van Deusen K, Baiocchi R, Wu L, Kwiek J. A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4+ T-cells. 2015, 7: 1-5. PMID: 26855567, PMCID: PMC4739806, DOI: 10.4137/rrt.s31632.
- Hartlage A, Liu T, Patton J, Garman S, Zhang X, Kurt H, Lozanski G, Lustberg M, Caligiuri M, Baiocchi R. The Epstein–Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development. Cancer Immunology Research 2015, 3: 787-794. PMID: 25735952, PMCID: PMC4491000, DOI: 10.1158/2326-6066.cir-14-0242.
- Lustberg M, Pelletier R, Porcu P, Martin S, Quinion C, Geyer S, Caligiuri M, Baiocchi R. Human Leukocyte Antigen Type and Posttransplant Lymphoproliferative Disorder. Transplantation 2015, 99: 1220-1225. PMID: 25427163, DOI: 10.1097/tp.0000000000000487.
- Hartlage A, Liu T, Patton J, Garman S, Zhang X, Kurt H, Lozanski G, Lustberg M, Caligiuri M, Baiocchi R. The Epstein-Barr Virus Lytic Protein BZLF1 As a Candidate Target Antigen for Vaccine Development. Blood 2014, 124: 4144. DOI: 10.1182/blood.v124.21.4144.4144.
- Dugan J, Haverkos B, Martin L, Martin M, Lustberg M, Patton J, Nuovo G, Yan F, Cavaliere R, Kenney S, Fingeroth J, Lozanski G, Ramos J, Porcu P, Caligiuri M, Baiocchi R. Epstein-Barr Virus Kinase-Targeted Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder. Blood 2014, 124: 1750. DOI: 10.1182/blood.v124.21.1750.1750.
- Patton J, Lustberg M, Lozanski G, Garman S, Towns W, Drohan C, Lehman A, Zhang X, Bolon B, Pan L, Kinghorn A, Grever M, Lucas D, Baiocchi R. The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease. Oncotarget 2014, 6: 2693-2708. PMID: 25393910, PMCID: PMC4413611, DOI: 10.18632/oncotarget.2098.
- Haverkos B, Hemminger J, Geyer S, Bingman A, Van Deusen K, Lustberg M, Wong H, Gru A, Ambinder R, Baiocchi R, Porcu P. Prognostic implications, predictive value, and latency analysis of Epstein-Barr virus (EBV) DNA in advanced stage cutaneous T-cell lymphoma (AS-CTCL). Journal Of Clinical Oncology 2014, 32: e19518-e19518. DOI: 10.1200/jco.2014.32.15_suppl.e19518.
- Yan F, Alinari L, Lustberg M, Martin L, Cordero-Nieves H, Banasavadi-Siddegowda Y, Virk S, Barnholtz-Sloan J, Bell E, Wojton J, Jacob N, Chakravarti A, Nowicki M, Wu X, Lapalombella R, Datta J, Yu B, Gordon K, Haseley A, Patton J, Smith P, Ryu J, Zhang X, Mo X, Marcucci G, Nuovo G, Kwon C, Byrd J, Chiocca E, Li C, Sif S, Jacob S, Lawler S, Kaur B, Baiocchi R. Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma. Cancer Research 2014, 74: 1752-1765. PMID: 24453002, PMCID: PMC3959215, DOI: 10.1158/0008-5472.can-13-0884.
- Abandeh F, Lustberg M, Devine S, Elder P, Andritsos L, Martin S. Outcomes of hematopoietic SCT recipients with rhinovirus infection: a matched, case–control study. Bone Marrow Transplantation 2013, 48: 1554-1557. PMID: 23872740, PMCID: PMC4606879, DOI: 10.1038/bmt.2013.100.
- Lustberg M, Bauer K. How Much Is a Life Worth? Food for Thought. Clinical Infectious Diseases 2013, 57: 627-628. PMID: 23658432, PMCID: PMC3719888, DOI: 10.1093/cid/cit311.
- Sopirala M, Smyer J, Fawley L, Mangino J, Lustberg M, Lu J, Chucta S, Crouser E. Sustained reduction of central line–associated bloodstream infections in an intensive care unit using a top-down and bottom-up approach. American Journal Of Infection Control 2013, 41: 183-184. PMID: 23369315, DOI: 10.1016/j.ajic.2012.07.013.
- Exline M, Ali N, Zikri N, Mangino J, Torrence K, Vermillion B, St Clair J, Lustberg M, Pancholi P, Sopirala M. Beyond the bundle - journey of a tertiary care medical intensive care unit to zerocentral line-associated bloodstream infections. Critical Care 2013, 17: r41. PMID: 23497591, PMCID: PMC3733431, DOI: 10.1186/cc12551.
- Hofmeister C, Bowers M, Bingman A, Lozanski G, Baiocchi R, Falk W, Benson D, Efebera Y, Humphries K, Sell M, Greenfield C, Lustberg M, Vaughn J, Earl C, Geyer S, Devine S. Immune Reconstitution and Quality of Life Analyses After Autologous Transplant for Multiple Myeloma. Blood 2012, 120: 4460. DOI: 10.1182/blood.v120.21.4460.4460.
- Alinari L, Yan F, Smith P, Patton J, Quinion C, Yu B, Earl C, Lustberg M, Villagomez L, Hertlein E, Byrd J, Ayers L, Motiwala T, Majumder S, Li C, Sif S, Jacob S, Baiocchi R. Protein Arginine Methyltransferase 5 (PRMT5) Over-Expression Is Essential for Epstein-Barr Virus-Driven B-Cell Transformation. Blood 2012, 120: 2378. DOI: 10.1182/blood.v120.21.2378.2378.
- Hofmeister C, Bowers M, Baiocchi R, Lozanski G, Humphries K, Blum K, Porcu P, Penza S, Greenfield C, Sell M, Earl C, Zitesman J, Quinion C, Lustberg M, Andritsos L, Devine S. Post Autologous Transplant Vorinostat (SAHA) in High Risk Lymphoma: Phase 1 Study of Vorinostat Maintenance. Blood 2012, 120: 2004. DOI: 10.1182/blood.v120.21.2004.2004.
- Stevenson K, Balada-Llasat J, Bauer K, Deutscher M, Goff D, Lustberg M, Pancholi P, Reed E, Smeenk D, Taylor J, West J. The Economics of Antimicrobial Stewardship: The Current State of the Art and Applying the Business Case Model. Infection Control And Hospital Epidemiology 2012, 33: 389-397. PMID: 22418635, DOI: 10.1086/664910.
- Martin L, Lustberg M, Yan F, Patton J, Porcu P, Nuovo G, Cavaliere R, Baiocchi R. Successful Treatment of Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder (PCNS-PTLD) with Zidovudine (AZT), Ganciclovir (GCV), Rituximab and Dexamethasone: A Single-Institution Case Series. Blood 2011, 118: 3067. DOI: 10.1182/blood.v118.21.3067.3067.
- Lustberg M, Pelletier R, Porcu P, Martin S, Baiocchi R. Risk Factors for Post-Transplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients. Blood 2011, 118: 4465. DOI: 10.1182/blood.v118.21.4465.4465.
- Patton J, Lustberg M, Garman S, Kinghorn A, Pan L, Lucas D, Grever M, Baiocchi R. Silvestrol Modulates Direct Anti-Tumor Activity Against Epstein-Barr Virus (EBV)-Associated Lymphomas While Sparing Innate and Antigen Specific Adaptive Immunity. Blood 2011, 118: 104. DOI: 10.1182/blood.v118.21.104.104.
- Christian B, Alinari L, Jones J, Benson D, Flynn J, Porcu P, Lustberg M, Phelps M, Poi M, Chung D, Quinion C, Byrd J, Wegener W, Goldenberg D, Baiocchi R, Blum K. Results of A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma,. Blood 2011, 118: 3707. DOI: 10.1182/blood.v118.21.3707.3707.
- Alinari L, Yu B, Christian B, Yan F, Shin J, Lapalombella R, Hertlein E, Lustberg M, Quinion C, Zhang X, Lozanski G, Muthusamy N, Prætorius-Ibba M, O'Connor O, Goldenberg D, Byrd J, Blum K, Baiocchi R. Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma. Blood 2011, 117: 4530-4541. PMID: 21228331, PMCID: PMC3099572, DOI: 10.1182/blood-2010-08-303354.
- Baiocchi R, Alinari L, Lustberg M, Lin T, Porcu P, Li X, Johnston J, Byrd J, Blum K. Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma. Cancer 2010, 117: 2442-2451. PMID: 24048792, PMCID: PMC3116936, DOI: 10.1002/cncr.25792.
- Christian B, Alinari L, Earl C, Wilding E, Quinion C, Lustberg M, Benson D, Jones J, Byrd J, Wegener W, Goldenberg D, Baiocchi R, Blum K. A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma. Blood 2010, 116: 2788. DOI: 10.1182/blood.v116.21.2788.2788.
- Ramaswamy B, Phelps M, Baiocchi R, Bekaii-Saab T, Ni W, Lai J, Wolfson A, Lustberg M, Wei L, Wilkins D, Campbell A, Arbogast D, Doyle A, Byrd J, Grever M, Shah M. A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors. Investigational New Drugs 2010, 30: 629-638. PMID: 20938713, PMCID: PMC3486515, DOI: 10.1007/s10637-010-9563-7.
- Lustberg M, Bekaii-Saab T, Young D, Otterson G, Burak W, Abbas A, McCracken-Bussa B, Lustberg M, Villalona-Calero M. Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients with Unresectable Esophageal and Gastroesophageal Adenocarcinoma. Journal Of Thoracic Oncology 2010, 5: 713-718. PMID: 20354452, PMCID: PMC3641556, DOI: 10.1097/jto.0b013e3181d7776d.
- Lustberg M, Schlesinger L, Mangino J. Concerns about “Complicated Skin and Skin-Structure Infections and Catheter-Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study”. Clinical Infectious Diseases 2009, 49: 313-313. PMID: 19538067, PMCID: PMC4117394, DOI: 10.1086/600056.
- Lustberg M. Shock as a Covariate in a Study of Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Clinical Infectious Diseases 2008, 46: 1483-1483. PMID: 18419465, DOI: 10.1086/587178.
Departments and Programs
Locations
Yale Infectious Diseases
Yale Center for Infectious Disease
200 Orchard Street, Fl 1
New Haven, CT 06511
- Yale Infectious DiseasesYale Center for Infectious Disease200 Orchard Street, Fl 1New Haven, CT 06511
Yale Infectious Diseases
Yale Center for Infectious Disease
200 Orchard Street, Fl 1
New Haven, CT 06511
- Yale Infectious DiseasesYale Center for Infectious Disease200 Orchard Street, Fl 1New Haven, CT 06511